Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin

Abstract

Our work describes a progressive series of assays to demonstrate the potential clinical value of a novel RORγ inverse agonist small molecule with high potency and selectivity, which will enter clinical trials in late 2015 for psoriasis patients.